Search results: Found 2

Listing 1 - 2 of 2
Sort by
Assessment of Cellular and Organ Function and Dysfunction using Direct and Derived MRI Methodologies

ISBN: 9789535127222 9789535127239 Year: Pages: 116 DOI: 10.5772/61953 Language: English
Publisher: IntechOpen
Subject: Medicine (General)
Added to DOAB on : 2019-10-03 09:47:10

Export citation

Choose an application


Despite the tremendous growth in the field of magnetic resonance imaging (MRI) evidenced in the initial phases of its development in the early twentieth century, scientific focus has shifted in recent years toward the study of physiology and pathophysiology that span the spatial scales of the molecule, cell, tissue, and organ. Intensified research activities over the past 15 years have justified efforts toward molecular and cellular imaging, dual-modality imaging systems, real-time acquisitions, dedicated image processing techniques and applications, and the critical evaluation of their potential translational value for use in the clinic. The integrative focus on molecular-cellular-tissue-organ function and dysfunction has taken a primary role in modern, personalized medicine, and it is envisaged to continue to do so, as accumulated knowledge from basic and clinical science work continues to elucidate molecular, cellular, and physiological/pathophysiological pathways and mechanisms. In this scientific effort, MRI continues to play a critical and synergistic role from the perspectives of basic science, diagnosis, and clinical interventional/therapeutic approaches. Within the realm of the current role of MRI in modern medicine, this book summarizes state-of-the-art direct and derived MRI methodologies and approaches as applied toward the assessment of cellular and organ function and dysfunction. The contributions in this effort are not excessive but few, comprehensive, and distinguished and of high quality. The topic areas can be generalized to find applications in other scientific areas and span both brain and cardiac applications, extending interest to wider audiences.

Biomarkers of Alzheimer's Disease: The Present and the Future

Authors: ---
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889450411 Year: Pages: 218 DOI: 10.3389/978-2-88945-041-1 Language: English
Publisher: Frontiers Media SA
Subject: Science (General) --- Neurology
Added to DOAB on : 2018-02-27 16:16:44

Export citation

Choose an application


Alzheimer disease (AD) is a neurodegenerative disorder characterized by significant cognitive deficits, behavioral changes, sleep disorders and loss of functional autonomy. AD represents the main cause of dementia and has become a major public health issue. In addition, the number of patients suffering from AD is growing rapidly as the population ages worldwide. Memory impairment is usually the earliest clinical and core symptom of this disease. The diagnosis at a late clinical stage is relatively easy. However, a delay in the diagnosis is damageable for the handling of patients in terms of optimal medical and social care. The actual interest of the scientific head-ways is to optimize the diagnosis in prodromal stage of the disease and to propose personalized therapeutic solutions to individual patients. New revised AD diagnostic criteria include early alteration of cerebrospinal fluid (CSF) biomarkers: decrease of amyloïd peptides (Aß42), and increase in tau and phosphorylated-tau (p-tau) protein concentration. This recognition of CSF biological biomarkers for the diagnosis of AD is a major step towards the “molecular” diagnosis and follow-up of the disease. Many issues are however still subject of debate. This e-book provides a comprehensive overview of the state of the art of fluid biomarkers for AD, e.g. which novel biomarkers should be implemented in clinical practice for diagnosis or for monitoring treatment or side effects, which ones are new for AD or related dementias or what is the potential of peripheral blood markers. Moreover, the e-Book provides practical guidelines how to optimally and efficiently develop and validate novel biomarker assays, and to document and control pre-analytical variation.

Listing 1 - 2 of 2
Sort by
Narrow your search


Frontiers Media SA (1)

IntechOpen (1)


CC by (1)

unknown (1)


english (2)

From To Submit

2016 (2)